Comparison of competing-risks model with angiogenic factors in midgestation screening for preterm growth-related neonatal morbidity.

Papastefanou, I; Menenez, M; Szczepkowska, A; Gungil, B; Syngelaki, A; Nicolaides, K H

Papastefanou, I; Menenez, M; Szczepkowska, A; Gungil, B; Syngelaki, A; Nicolaides, K H.

Afiliação

Papastefanou I; Department of Women and Children's Health, School of Life Course and Population Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Menenez M; Fetal Medicine Research Institute, King's College Hospital, London, UK.
Szczepkowska A; Fetal Medicine Research Institute, King's College Hospital, London, UK.
Gungil B; Fetal Medicine Research Institute, King's College Hospital, London, UK.
Syngelaki A; Department of Women and Children's Health, School of Life Course and Population Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Nicolaides KH; Fetal Medicine Research Institute, King's College Hospital, London, UK.

Ultrasound Obstet Gynecol ; 2023 Dec 06.

Article em En | MEDLINE | ID: mdl-38057964

Palavras-chave

angiogenic factor; anti-angiogenic factor; growth restriction; neonatal morbidity; neonatal unit admission; placental growth factor; second trimester screening; small for gestational age; soluble fms-like tyrosine kinase-1; stratification

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido